Jim Pearce

Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and manages two trading services, PF Pro and Mayhem Trader. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms, and investment advisors. Jim earned a BA from The College of William & Mary and the CFP designation from the College of Financial Planning.

Analyst Articles

As described in today’s issue of Smart Tech Investor, we are adding the three cancer-fighting companies described in our recent special report, “One Little Shot to Kill Cancer Dead“, to the new STI Special Situations Portfolio. Those stocks are Argos Therapeutics (ARGS), Juno Therapeutics (JUNO), and Ziopharm Oncology (ZIOP). Read More

Due to last Monday’s Presidents Day holiday the stock market was open for only four days last week instead of the usual five, but that’s all the time it needed to gain nearly 3% – one of its strongest showings in 2016. In fact, after hitting its closing low of… Read More

Due to last Monday’s Presidents Day holiday the stock market was open for only four days last week instead of the usual five, but that’s all the time it needed to gain nearly 3% – one of its strongest showings in 2016. In fact, after hitting its closing low of… Read More

With all the bad news out there it is sometimes difficult to keep in mind that investor capital never stops chasing opportunity, no matter what the circumstances. Read More

It had to happen sooner or later; after soundly beating the overall market in 2015, the tech sector is now taking its turn under the harsh glare of market scrutiny. As a result, the tech-heavy NASDAQ Composite Index declined 5.5% the first week of February, coming on the heels of… Read More